Medication info
Youngtraset Tablet

Youngtraset Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200804696 · Notified 2008.04.25 · Insurance code 642401930

Summary

Main use
Relief of moderate~severe acute·chronic pain
Who takes it
Adults · Children
Adult dose
Elderly The usual adult dose should be administered. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, this medicine should be administered at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), the dosing interval should be extended to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance of less than 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with moderate hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate~severe acute·chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used for acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly The usual adult dose should be administered. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, this medicine should be administered at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), the dosing interval should be extended to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance of less than 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with moderate hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day.

Precautions

This medication may pose a risk of liver damage for individuals who regularly consume more than three glasses of alcohol per day, so it should only be taken after consultation with a doctor or pharmacist. If a rash, blistering, or severe allergic reaction occurs while taking this medication, discontinue use immediately and seek a doctor's care. Caution is required as tramadol, the main ingredient of this medication, can increase the risk of seizures when taken in excessive doses or with certain antidepressants and narcotics. This medication can cause severe respiratory depression in patients with acute asthma; thus, it should be administered in a medically equipped setting if needed. The concurrent use of this drug with benzodiazepines or alcohol can result in severe sedation, respiratory depression, or coma, so co-administration should be avoided or undertaken with extreme caution. Caution is also advised for patients with head injuries or elevated intracranial pressure, as respiratory depression from this medication could further increase intracranial pressure. This medication may lead to mental and physical dependence; therefore, if taken for an extended period, dependence should be discussed and managed with healthcare professionals. Patients with poor liver function should consult a doctor before taking this medication to avoid excess acetaminophen consumption, which can prevent liver damage. This medication carries a heightened risk of respiratory depression in individuals with extremely rapid CYP2D6 enzyme activity, requiring special monitoring. Children under 12 years or those under 18 years who have undergone tonsillectomy or adenoidectomy should not be administered this medication, and adolescents aged 12 to 18 years should avoid it if there are special risk factors. Patients with sleep apnea or hypoxia may experience worsening symptoms after taking this medication, so careful observation of symptom changes is advised. This medication can occasionally induce hyponatremia, leading to low sodium levels; thus, monitoring is necessary, especially for elderly patients or those with risk factors. Patients who are allergic to any components of this medication, or those with severe respiratory depression, head injuries, or taking MAO inhibitors should not take it. Abrupt discontinuation during treatment can trigger withdrawal symptoms such as anxiety, insomnia, and tremors, hence dosage should be tapered off gradually under medical advice. Caution is advised during activities requiring alertness, such as driving or operating machinery, as drowsiness or dizziness may occur. In case of overdose, serious side effects such as respiratory depression, seizures, or liver damage may arise, necessitating immediate medical attention for appropriate treatment. This medication should be stored in a secure place, out of reach of children, and care should be taken to prevent misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, spatial disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, drowsiness, sensory impairment, tremors, paresthesia, attention deficit, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, throat dryness, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased blood creatinine, anaphylaxis reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal thoughts, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatiguelactic acidosis, hyponatremia, fixed rash, weakness, fever, edema, rigidity, fainting, congestive heart failure, confusion, tension hypertension, exacerbation of migraine, involuntary muscle contractions, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequency of urination, abnormal renal function levels, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, hematochezia, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal visual fields, progression of biliary tract cancer, sensation of foreign body in the eye, progression of liver cancer, abnormal liver function, nausea, vertigo, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory tract syndrome, dry mouth, agitation, hyperactivity, withdrawal symptoms, panic attack, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, symptoms of acute or chronic adrenal insufficiency (severe abdominal pain, nausea, vomiting, hypotension, extreme fatigue, decreased appetite, weight loss)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.